Actively Recruiting
Study of Dietary Protein Supplementation to Prevent Muscle Wasting in Adults with Heart Failure Comparing No, Low, and High Protein Doses Using Ensure Products
Led by Tufts Medical Center · Updated on 2025-11-25
120
Participants Needed
2
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to study muscle loss in patients with heart failure with reduced ejection fraction HFrEF, a condition where the heart does not pump blood effectively. It focuses on severe muscle wasting and weight loss common in these patients. The trial will explore whether increasing dietary protein intake can help reverse muscle loss, and it also examines biological pathways like GDF-15 and ActRII that may drive this muscle wasting. Participants will be randomly assigned to one of three groups receiving different levels of protein supplementation using Ensure products by Abbott Nutrition. One group receives a high dose of 30 grams protein daily Ensure Max Protein, another a low dose of 9 grams protein daily Ensure Original, and the third group receives no supplementation. The intervention lasts for 6 months with monitoring at 3 and 6 months. During the study, participants will have their muscle mass measured in arms and legs appendicular lean mass at 3 and 6 months. Additional assessments include handgrip strength, walking ability with a 6-minute walk test, and physical performance tests. Researchers will monitor protein intake and evaluate safety throughout the trial, which is sponsored by Tufts Medical Center and runs up to 2027.
CONDITIONS
Brief Title
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
Research Team
A
Amanda R Vest, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here